Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced fluid resuscitation in severe traumatic brain injury to reduce hyperchloremic acidosis
2008-004153-15Phase 3Active
- Sponsor
- CHU de Nantes
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of sterofundin, sodium chloride, hydroxyethyl starch 130/0.42 and gelatin in traumatic brain injury (TBI) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Incidence of hyperchloremic acidosis during the first 2 days. Started Aug 2008; status: active.
02
Drugs
sterofundinsodium chloridehydroxyethyl starch 130/0.42gelatin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2008-004153-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004153-15.